We demonstrate that this mutant adenovirus exerted a p53-dependent cytolytic effect on bladder cancer cells and its antitumour effect could be augmented when combined with E1-deleted adenoviral vector encoding K1–5. The gene discussed is TP53; the disease is urinary bladder carcinoma.